Duriye Ozturk

7PUBLICATIONS
10CO-AUTHORS
Radiation therapyTumour immunologyGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 08, 2025
A higher number of chemotherapy cycles given during and after radiation is linked to increased rates of radiation-induced trismus in locally advanced nasopharyngeal cancer patients.

Efsun Somay, Erkan Topkan, Sibel Bascil

|Oct 27, 2025
Letter to the editor: a comparison of outcomes after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases: an international multi-center study.

Erkan Topkan, Duriye Ozturk

|Oct 08, 2024
Novel Index Combining Pan-Immune-Inflammatory Index and Hemoglobin Levels (PIV/Hb) Predicts Trismus Rates Efficiently after Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer.

Efsun Somay, Busra Yilmaz, Erkan Topkan

|Sep 21, 2024
The global immune-nutrition-inflammation index (GINI) as a robust prognostic factor in glioblastoma patients treated with the standard stupp protocol.

Erkan Topkan, Nilufer Kilic Durankus, Sukran Senyurek

|Sep 03, 2024
Comment on 'Osteoradionecrosis incidence in pre-radiation teeth extractions: A prospective study.

Efsun Somay, Duriye Ozturk, Erkan Topkan

|Jul 08, 2024
Prognostic Value of Novel CARWL Score in Stage IIIC Non-Small-Cell Lung Cancer Patients Undergoing Concurrent Chemoradiotherapy.

Erkan Topkan, Ahmet Kucuk, Duriye Ozturk

Pageof 2

Frequent Collaborators

7 joint publications

Erkan Topkan

3 joint publications

Ugur Selek

3 joint publications

Efsun Somay

1 joint publications

Ahmet Kucuk